Position in ALKS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$689,636
+$222,849 QoQ
Shares Held
13,161
-0.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#230
of 421 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jackson Creek Investment Advisors LLC holds $8,805,246 across 7 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
49,619 | $2,035,867 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
10,642 | $1,793,602 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
42,663 | $1,544,400 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
14,298 | $1,183,588 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
40,140 | $987,845 | |
| 6 | ALKS |
Alkermes plc.
This page
|
13,161 | $689,636 | |
| 7 | LQDA |
Liquidia Corp
|
7,153 | $570,308 |
All Filings in ALKS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $689,636 | 13,161 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $466,787 | 13,201 | Shares | Sole | 2026-05-05 | |
| 2023-09-30 | $976,008 | 34,845 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,091,211 | 34,863 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $904,053 | 32,070 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $838,198 | 32,078 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $742,852 | 33,267 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,041,786 | 34,971 | Shares | Sole | 2022-08-04 | |
| 2021-09-30 | $1,297,593 | 42,075 | Shares | Sole | 2021-11-02 | |
| No filing history on record for this holder in this stock. | ||||||